Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Feb 6, 2026
- Accession no.
- 0001601830-26-000008
- Filed
- Feb 6, 2026
- Trade date
- Feb 4-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $164.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Class A Common Stock | CConversionAcquired | +40,000 | $0.00 | $0 | 953,839 | Direct | |
| Feb 4, 2026 | Class A Common Stock | SSaleDisposed | −40,000 | $4.12 | −$164,800 | 913,839 | Direct | |
| Feb 6, 2026 | Class A Common Stock | AGrant or awardAcquired | +30,346 | $0.00 | $0 | 944,185 | Direct | |
| Feb 6, 2026 | Class A Common Stock | FTax withholdingDisposed | −10,364 | $3.56 | −$36,895.84 | 933,821 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Class A Common Stock | CConversionDisposed | −40,000 | $0.00 | $0 | 4,583,334 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.